Coronavirus news highlights: Maharashtra reports 4,304 new Covid-19 cases and 95 deaths
In its most recent update, the Union Health Ministry placed the total number of cases at 99,40,831 and the death toll at 1,44,260. The ministry said that 94,7,8375 people have so far recovered from the infection. According to Deccan Herald's calculations, the total number of confirmed positive cases in India has reached 99,46,583 and the death toll stands at 1,44,348 as of December 16. Stay tuned on DH for more latest updates.
We're fully prepared on how to vaccinate people when vaccines will be available. We have also planned on how vaccines will be stored and transported. We've prepared sites where vaccines will be stored: Manoj Parida, Advisor, Chandigarh Administration.
22:2116 Dec 2020
Maharashtra reports 4,304 new Covid-19 cases, 95 deaths and 4,678 discharges today.
22:2016 Dec 2020
Behind in vaccine race, CureVac bets on 'easier' jab
CureVac CEO Franz-Werner Haas readily admits his German biotech firm is "a bit behind" in the Covid-19 vaccine race, despite using the same cutting-edge technology as rivals Moderna and Pfizer/BioNTech.
Seronegative-first plan makes better vaccine sense, suggests study
While the government is yet to take a call on such a critical issue, a new study has shown that preferentially vaccinating seronegative individuals — who were not exposed to the virus and who tested negative in antibody tests — yielded large additional reductions in cumulative incidence and mortality.
Bharat Biotech's Covid-19 vaccine well tolerated with no serious adverse events: Ph 1 trial findings
The interim findings of the phase 1 clinical trial of the Covid-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the ICMR, showed that it was well tolerated in all dose groups with no serious or adverse events.